drugset
drugset / Trial / NCT05453916

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

NCT05453916 ↗

Phase 1/2 Withdrawn Sadat City University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aim to compare the efficacy of nitazoxanide in 2-week course of treatment with rifaximin in treating diarrhea associated with IBS. We also aim to study its effect over 10 weeks after treatment to evaluate its efficacy in eradicating symptoms of IBS in the long run.

Timeline

Start
2022-07-01
Primary completion
2024-07-01
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified 500 mg Oral
Comparator Rifaximin Other / unclassified 550 mg —

Indications

irritable bowel syndrome